- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/28 - Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
Patent holdings for IPC class A61K 47/28
Total number of patents in this class: 1361
10-year publication summary
|
57
|
74
|
119
|
106
|
110
|
120
|
152
|
160
|
166
|
6
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| FUJIFILM Corporation | 28467 |
51 |
| Modernatx, Inc. | 1209 |
41 |
| Taiwan Liposome Co., Ltd. | 85 |
23 |
| TLC Biopharmaceuticals, Inc. | 70 |
23 |
| Translate bio, Inc. | 411 |
20 |
| The Regents of the University of California | 19479 |
18 |
| ReCode Therapeutics, Inc. | 44 |
16 |
| Terumo Kabushiki Kaisha | 5368 |
15 |
| National University Corporation Hokkaido University | 1330 |
15 |
| NOK Corporation | 2161 |
15 |
| SDG, Inc. | 33 |
14 |
| Arbutus Biopharma Corporation | 189 |
13 |
| Ipsen Biopharm Limited | 269 |
13 |
| National University Corporation Chiba University | 489 |
13 |
| Alnylam Pharmaceuticals, Inc. | 1128 |
12 |
| Daiichi Sankyo Company, Limited | 1863 |
12 |
| Eisai R&D Management Co., Ltd. | 1271 |
12 |
| Massachusetts Institute of Technology | 9903 |
10 |
| Insmed Incorporated | 220 |
10 |
| Alkermes Pharma Ireland Limited | 289 |
9 |
| Other owners | 1006 |